A US-based, leading life sciences company approached Freyr for Regulatory support in compiling, evaluating, and submitting CBE 30 to the United States Food and Drug Administration (USFDA). The project involved reviewing various documents from the customer, identifying the gaps, and compiling the relevant data required for the CBE 30.
Know more about how Freyr helped the customer meet their business requirements in defined timelines and ensured the successful submission of CBE 30 to the United States Food and Drug Administration (USFDA). Download the proven case.